Prophylactic corticosteroids do not prevent post-ercp pancreatitis: A meta-analysis of randomized controlled trials

Pancreatology

Volumn 8, Issue 4-5, 2008, Pages 504-509

  Bai, Yu ^a   Gao, Jun ^a   Shi, Xingang ^a   Zou, Duowu ^a   Li, Zhaoshen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Corticosteroids; Endoscopic retrograde cholangiopancreatography; Pancreatitis

Indexed keywords

HYDROCORTISONE; METHYLPREDNISOLONE; PLACEBO; PREDNISONE;

ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EMBASE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MEDLINE; META ANALYSIS; MULTICENTER STUDY; OUTCOME ASSESSMENT; PANCREATITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCISEARCH; SENSITIVITY ANALYSIS;

EID: 48449102689     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000151999     Document Type: Article

References (25)

1. Loperfido S, Angelini G, Benedetti G, et al: Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998;48:1-10.
2. Cheng CL, Sherman S, Watkins JL, et al: Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 2006;101:139-147.
3. Weiner GR, Geenen JE, Hogan WJ, et al: Use of corticosteroids in the prevention of post-ERCP pancreatitis. Gastrointest Endosc 1995;42:579-583.
4. De Palma GD, Catanzano C: Use of corticosteroids in the prevention of post-ERCP pancreatitis: results of a controlled prospective study. Am J Gastroenterol 1999;94:982-985.
5. Budzynska A, Marek T, Nowak A, et al: A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis. Endoscopy 2001;33:766-772.
6. Jadad AR, Moore RA, Carroll D, et al: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
7. Clarke M, Oxman AD: Cochrane Reviewers Handbook 4.0. Oxford, The Cochrane Collaboration, 2001.
8. Begg CB: Publication bias; in Cooper H, Hedges LV (eds): The Handbook of Research Synthesis. New York, Russell Sage Foundation, 1994, pp 399-410.
9. Dumot JA, Conwell DL, O'Connor JB, et al: Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial. Am J Gastroenterol 1998;93:61-65.
10. Manolakopoulos S, Avgerinos A, Vlachogiannakos J, et al: Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial. Gastrointest Endosc 2002;55:470-475.
11. Kwanngern K, Tiyapattanaputi P, Wanitpukdeedecha M, et al: Can a single dose corticosteroid reduce the incidence of post-ERCP pancreatitis? A randomized, prospective control study. J Med Assoc Thai 2005;88(suppl 4):S42-S45.
12. Sherman S, Blaut U, Watkins JL, et al: Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study. Gastrointest Endosc 2003;58:23-29.
13. Budzynska A, Marek T, Nowak A, et al: Prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis. Gut 1997;41:48E-49E.
14. Andriulli A, Clemente R, Solmi L, et al: Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc 2002;56:488-495.
15. Poon RTP, Yeung C, Lo CM, Yuen WK, Liu CL, Fan ST: Prophylactic effect of Somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc 1999;49:593-598.
16. Li ZS, Pan X, Zhang WJ, et al: Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: a multicenter, placebo-controlled, randomized clinical trial. Am J Gastroenterol 2007;102:46-51.
17. Zheng M, Chen Y, Yang X, et al: Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. BMC Gastroenterol 2007;7:6.
18. Andriulli A, Leandro G, Federici T, et al: Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: An updated meta-analysis. Gastrointest Endosc 2007;64:624-633.
19. Lasser EC, Lang JH, Lyon SG, Hamblin AE, Howard M: Glucocorticoid-induced elevations of C-1-esterase inhibitor: a mechanism for protection against lethal dose range contrast challenge in rabbits. Invest Radiol 1981;16:20-23.
20. Bettinger JR, Grendel JH: Intracellular events in the pathogenesis of acute pancreatitis. Pancreas 1991;6(suppl 1):S2-S6.
21. Lasser EC, Berry CC, Talner LB, et al: Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. N Engl J Med 1987;317:845-849.
22. Bai Y, Li ZS: Results of meta-analysis should be interpreted with much caution. Am J Gastroenterol 2007;102:1826.
23. Cotton PB, Lehman G, Vennes J, et al: Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991;37:383-393.
24. Lempinen M, Stenman UH, Halttunen J, et al: Early sequential changes in serum markers of acute pancreatitis induced by endoscopic retrograde cholangiopancreatography. Pancreatology 2005;5:157-164.
25. Vege SS, Chari ST, Petersen BT, et al: Endoscopic retrograde cholangiopancreatography-induced severe acute pancreatitis. Pancreatology 2006;6:527-530.